Phenotypic characterization of autoreactive T cells in multiple sclerosis

Journal of Neuroimmunology

Volumn 178, Issue 1-2, 2006, Pages 100-110

  Ratts, Robert B ^a   Karandikar, Nitin J ^a   Hussain, Rehana Z ^a   Choy, Judy ^a   Northrop, Sara C ^a   Lovett Racke, Amy E ^a   Racke, Michael K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Autoimmunity; CD81; T cells

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; MYELIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; MULTIPLE SCLEROSIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIGENS, CD28; ANTIGENS, CD57; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN SHEATH; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33748121187     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.06.010     Document Type: Article

References (47)

1. The Canadian Cooperative Trial of Cyclophosphamide and Plasma Exchange in Progressive Multiple Sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group. Lancet 337 (1991) 441-446
2. Abo T., and Balch C.M. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J. Immunol. 127 (1981) 1024-1029
3. Babbe H., Roers A., Waisman A., Lassmann H., Goebels N., Hohlfeld R., Friese M., Schroder R., Deckert M., Schmidt S., Ravid R., and Rajewsky K. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192 (2000) 393-404
4. Balashov K.E., Rottman J.B., Weiner H.L., and Hancock W.W. CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. PNAS 96 (1999) 6873-6878
5. Brenchley J.M., Karandikar N.J., Betts M.R., Ambrozak D.R., Hill B.J., Crotty L.E., Casazza J.P., Kuruppu J., Migueles S.A., Connors M., Roederer M., Douek D.C., and Koup R.A. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101 (2003) 2711-2720
6. Cebo C., Durier V., Lagant P., Maes E., Florea D., Lefebvre T., Strecker G., Vergoten G., and Zanetta J.P. Function and molecular modeling of the interaction between human interleukin 6 and its HNK-1 oligosaccharide ligands. J. Biol. Chem. 277 (2002) 12246-12252
7. Crawford M.P., Yan S.X., Ortega S.B., Mehta R.S., Hewitt R.E., Price D.A., Stastny P., Douek D.C., Koup R.A., Racke M.K., and Karandikar N.J. High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103 (2004) 4222-4231
8. Edan G., Miller D., Clanet M., Confavreux C., Lyon-Caen O., Lubetzki C., B.B., Berry I., Rolland Y., Froment J.C., Cabanis E., Iba-Zizen M.T., Gandon J.M., Lai H.M., Moseley I., and O.S. Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria. J. Neurol. Neurosurg. Psychiatry 62 (1997) 112-118
9. Eugster H.P., Frei K., Kopf M., Lassmann H., and Fontana A. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28 (1998) 2178-2187
10. Field M.C., Wing D.R., Dwek R.A., Rademacher T.W., Schmitz B., Bollensen E., and Schachner M. Detection of multisulphated N-linked glycans in the L2/HNK-1 carbohydrate epitope expressing neural adhesion molecule P0. J. Neurochem. 58 (1992) 993-1000
11. Filbin M.T., and Tennekoon G.I. The role of complex carbohydrates in adhesion of the myelin protein, P0. Neuron 7 (1991) 845-855
12. Filbin M.T., and Tennekoon G.I. Homophilic adhesion of the myelin P0 protein requires glycosylation of both molecules in the homophilic pair. J. Cell Biol. 122 (1993) 451-459
13. Hartung H.-P., Gonsette R., Konig N., Kwiecinski H., Guseo A., Morrissey S.P., Krapf H., and Zwingers T. Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial. Lancet 360 (2002) 2018-2025
14. Hellings N., Barée M., Verhoeven C., D'hooghe M.B., Medaer R., Bernard C.C.A., Raus J., and Stinissen P. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls. J. Neurosci. Res. 63 (2001) 290-302
15. Huseby E.S., Liggitt D., Brabb T., Schnabel B., Ohlen C., and Goverman J. A pathogenic role for myelin-specific CD8+ T cells in a model for multiple sclerosis. J. Exp. Med. 194 (2001) 669-676
16. Jacobsen M., Cepok S., Quak E., Happel M., Gaber R., Ziegler A., Schock S., Oertel W.H., Sommer N., and Hemmer B. Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients. Brain 125 (2002) 538-550
17. Janssen E.M., Lemmens E.E., Wolfe T., Christen U., von Herrath M.G., and Schoenberger S.P. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421 (2003) 852-856
18. Jingwu Z., Medaer R., Hashim G.A., Chin Y., van den Berg-Loonen E., and Raus J.C. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity. Ann. Neurol. 32 (1992) 330-338
19. Joshi N., Usuku K., and Hauser S.L. The T-cell response to myelin basic protein in familial multiple sclerosis: diversity of fine specificity, restricting elements, and T-cell receptor usage. Ann. Neurol. 34 (1993) 385-393
20. Kanda T., Yamawaki M., Ariga T., and Yu R.K. Interleukin 1 beta up-regulates the expression of sulfoglucuronosyl paragloboside, a ligand for L-selectin, in brain microvascular endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7897-7901
21. Karandikar N.J., Crawford M.P., Yan X., Ratts R.B., Brenchley J.M., Ambrozak D.R., Lovett-Racke A.E., Frohman E.M., Stastny P., Douek D.C., Koup R.A., and Racke M.K. Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis. J. Clin. Invest. 109 (2002) 641-649
22. Kreher C.R., Dittrich M.T., Guerkov R., Boehm B.O., and Tary-Lehmann M. CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays. J. Immunol. Methods 278 (2003) 79-93
23. Lovett-Racke A.E., Trotter J.L., Lauber J., Perrin P.J., June C.H., and Racke M.K. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. J. Clin. Invest. 101 (1998) 725-730
24. Maimone D., Guazzi G.C., and Annunziata P. IL-6 detection in multiple sclerosis brain. J. Neurol. Sci. 146 (1997) 59-65
25. Markovic-Plese S., Cortese I., Wandinger K.-P., McFarland H.F., and Martin R. CD4+ CD28- costimulation-independent T cells in multiple sclerosis. J. Clin. Invest. 108 (2001) 1185-1194
26. Mikol D.D., Gulcher J.R., and Stefansson K. The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate. J. Cell Biol. 110 (1990) 471-479
27. Mollet L., Sadat-Sowti B., Duntze J., Leblond V., Bergeron F., Calvez V., Katlama C., Debre P., and Autran B. CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity. Int. Immunol. 10 (1998) 311-323
28. Needham L.K., and Schnaar R.L. The HNK-1 reactive sulfoglucuronyl glycolipids are ligands for L-selectin and P-selectin but not E-selectin. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 1359-1363
29. Ott P.A., Berner B.R., Herzog B.A., Guerkov R., Yonkers N.L., Durinovic-Bello I., Tary-Lehmann M., Lehmann P.V., and Anthony D.D. CD28 costimulation enhances the sensitivity of the ELISPOT assay for detection of antigen-specific memory effector CD4 and CD8 cell populations in human diseases. J. Immunol. Methods 285 (2004) 223-235
30. Pelfrey C.M., Rudick R.A., Cotleur A.C., Lee J.-C., Tary-Lehmann M., and Lehmann P.V. Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production. J. Immunol. 165 (2000) 1641-1651
31. Schmidt D., Goronzy J.J., and Weyand C.M. CD4+CD7-CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J. Clin. Invest. 97 (1996) 2027-2037
32. Scholz C., Patton K.T., Anderson D.E., Freeman G.J., and Hafler D.A. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J. Immunol. 160 (1998) 1532-1538
33. Scotet E., Peyrat M.A., Saulquin X., Retiere C., Couedel C., Davodeau F., Dulphy N., Toubert A., Bignon J.D., Lim A., Vie H., Hallet M.M., Liblau R., Weber M., Berthelot J.M., Houssaint E., and Bonneville M. Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes. Eur. J. Immunol. 29 (1999) 973-985
34. Shy M.E., Gabel C.A., Vietorisz E.C., and Latov N. Characterization of oligosaccharides that bind to human anti-MAG antibodies and to the mouse monoclonal antibody HNK-1. J. Neuroimmunol. 12 (1986) 291-298
35. Skulina C., Schmidt S., Dornmair K., Babbe H., Roers A., Rajewsky K., Wekerle H., Hohlfeld R., and Goebels N. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2428-2433
36. Sriram S., and R.M. Indictment of the microglia as the villain in multiple sclerosis. Neurology 48 (1997) 464-470
37. Sun D., Whitaker J.N., Huang Z., Liu D., Coleclough C., Wekerle H., and Raine C.S. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166 (2001) 7579-7587
38. Sze D.M., Giesajtis G., Brown R.D., Raitakari M., Gibson J., Ho J., Baxter A.G., Fazekas de St Groth B., Basten A., and Joshua D.E. Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood 98 (2001) 2817-2827
39. Thiel A., Scheffold A., and Radbruch A. Antigen-specific cytometry-new tools arrived!. Clin. Immunol. 111 (2004) 155-161
40. Tomiyama H., Matsuda T., and Takiguchi M. Differentiation of human CD8+ T cells from a memory to memory/effector phenotype. J. Immunol. 168 (2002) 5538-5550
41. Van der Aa A., Hellings N., Bernard C.C.A., Raus J., and Stinissen P. Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls. J. Neuroimmunol. 137 (2003) 164-176
42. van Oosten B.W., L.M., Hodgkinson S., Barkhof F., Miller D.H., Moseley I.F., Thompson A.J., Rudge P., McDougall A., McLeod J.G., Ader H.J., and Polman C.H. Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. Neurology 49 (1997) 351-357
43. Wagner U.G., Koetz K., Weyand C.M., and Goronzy J.J. Perturbation of the T cell repertoire in rheumatoid arthritis. PNAS 95 (1998) 14447-14452
44. Weekes M.P., Wills M.R., Mynard K., Hicks R., Sissons J.G., and Carmichael A.J. Large clonal expansions of human virus-specific memory cytotoxic T lymphocytes within the CD57+CD28-CD8+ T-cell population. Immunology 98 (1999) 443-449
45. Woodroofe M.N., and Cuzner M.L. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine 5 (1993) 583-588
46. Yudkin P.L., Ellison G.W., Ghezzi A., Goodkin D.E., Hughes R.A., McPherson K., Mertin J., and Milanese C. Overview of azathioprine treatment in multiple sclerosis. Lancet 338 (1991) 1051-1055
47. Zang Y.C., Kozovska M.M., Hong J., Li S., Mann S., Killian J.M., Rivera V.M., and Zhang J.Z. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis. Eur. J. Immunol. 29 (1999) 1692-1700